Status:
RECRUITING
Product Surveillance Registry
Lead Sponsor:
Medtronic
Conditions:
Cardiac Rhythm Disorders
Urological Disorders
Eligibility:
All Genders
Brief Summary
The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and s...
Eligibility Criteria
Inclusion
- Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
- Patient has or is intended to receive or be treated with an eligible Medtronic product
- Patient within enrollment window relative to therapy initiation or meets criteria for retrospective enrollment
Exclusion
- Patient who is, or will be, inaccessible for follow-up
- Patient with exclusion criteria required by local law
- Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results
Key Trial Info
Start Date :
January 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2040
Estimated Enrollment :
100000 Patients enrolled
Trial Details
Trial ID
NCT01524276
Start Date
January 1 2012
End Date
January 1 2040
Last Update
December 24 2025
Active Locations (389)
Enter a location and click search to find clinical trials sorted by distance.
1
Birmingham, Alabama, United States
2
Huntsville, Alabama, United States
3
Chandler, Arizona, United States
4
Phoenix, Arizona, United States